Vascular mechanisms involved in angiotensin II-induced venoconstriction in hypertensive rats

详细信息    查看全文

• 作者：Rodrigo Azevedo Loiola^a ;   ; ^{rodrigoazl@gmail.com} ; Liliam Fernandes^b ; Rosâ ; ngela Eichler^a ; Rita de Cá ; ssia Tostes Passaglia^c ; Zuleica Bruno Fortes^a ; Maria Helena Catelli de Carvalho^a
• 关键词：Angiotensin II ; Venous system ; Hypertension ; Angiotensin receptors
• 刊名：Peptides
• 出版年：2011
• 出版时间：October 2011
• 年：2011
• 卷：32
• 期：10
• 页码：2116-2121
• 全文大小：588 K

文摘

To investigate the venoconstrictor effect of angiotensin II (Ang II) in spontaneously hypertensive rats (SHR), we used preparations of mesenteric venular beds and the circular muscle of the portal veins. Vessels were tested with Ang II in the presence or absence of losartan, PD 123319, HOE 140, L-NAME, indomethacin, or celecoxib. In the mesenteric venular bed of SHR, the effect of Ang II (0.1 nmol) was nearly abolished by losartan and enhanced by HOE 140, indomethacin, and celecoxib, while PD123319 and L-NAME had no effect. In portal vein preparations, cumulative-concentration response curves (CCRC) to Ang II (0.1?00 nmol/L) exhibited a lower maximal response (E_max) in SHR compared to Wistar rats. AT₁ receptor expression was similar in the two strains, while AT₂ receptor levels were lower in SHR portal veins when compared to Wistar. In SHR portal veins, losartan shifted the CCRC to Ang II to the right, while indomethacin and HOE 140 increased the E_max to Ang II. PD 123319, celecoxib, and L-NAME had no effect. Taken together, our results suggest that Ang II-induced venoconstriction in SHR is mediated by activation of AT₁ receptors and this effect may be counterbalanced by kinin B₂ receptor and COX metabolites. Furthermore, our data indicate that there are different cellular and molecular mechanisms involved in the regulation of venous tonus of normotensive and hypertensive rats. These differences probably reflect distinct factors that influence arterial and venous bed in hypertension.